Clinical Trial Update: Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study [Phase 2]

View source ↗

Summary

Completed Phase 2 tolerance study evaluating subcutaneous teicoplanin for osteoarticular infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarticular Infection

Drugs mentioned

• Teicoplanin (Teicoplanin)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Osteoarticular Infection | Phase 2 | Status: COMPLETED